Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00322686 · ClinicalTrials.gov registry record · Phase 2
Study of Oglemilast for the Treatment of Asthma
A Phase 2 study, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00322686 is a Phase 2 study that has completed, run by Forest Laboratories. The registered enrollment target is 6 participants.
The verdict
NCT00322686, a Phase 2 study, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether oglemilast is safe and effective in the treatment of allergen-induced asthma.
Interventions
- DRUG Oglemilast
- DRUG Placebo then Oglemilast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2006-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00322686
The ClinicalTrials.gov registry entry for NCT00322686 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oglemilast is the first listed.
NCT00322686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00322686 about?
NCT00322686 is a clinical study titled "Study of Oglemilast for the Treatment of Asthma". The purpose of this study is to determine whether oglemilast is safe and effective in the treatment of allergen-induced asthma.
What is the current status of trial NCT00322686?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2006-05.
What interventions are being tested in trial NCT00322686?
The interventions under investigation include: Oglemilast (DRUG), Placebo then Oglemilast (DRUG).
Who is sponsoring clinical trial NCT00322686?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.